SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation ...

Given the complexity of alternative-protein manufacturing, many biotech companies are exploring how to reduce costs with AI technologies, process improvements and novel uses for waste streams from ...

Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-105 using the Pichia pastoris expression system. “With ...

Startup Biosphere’s technology demonstrates the potential of UV sterilization for biomanufacturing, allowing biotech companies to replace costly infrastructure and improve scalability. Founded in 2022 ...

Arsenale Bioyards standardizes biomanufacturing from the industrial side, aiming to make biopharmaceutical manufacturing efficient, scalable, and cost-effective, much as the Bessemer converter did for ...

Process validation, including process characterization, is a critical step in the successful commercialization of a new biopharmaceutical on its path to commercialization. As the program approaches ...

The United States was a global manufacturing powerhouse. From the end of World War II into the 1970s, we were a dominant force in industrial production and manufacturing innovation. Since the late ...

XIANYANG CITY, SHAANXI PROVINCE, CHINA, January 21, 2026 /EINPresswire.com/ -- The pharmaceutical ingredients and ...

Selecting the right private label manufacturing biotech partner is a fundamental aspect of any product’s success on the market. This is why a large number of our clients establish long-term OEM ...

Houston-based clinical-stage biotechnology company FibroBiologics Inc. opened a manufacturing laboratory at 9350 Kirby Drive in the Texas Technology Park. It will bring manufacturing operations ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through ...